Drug intelligence / Profile preview

89Zr-Df-huB12

Development stage
Preclinical
Lead developer
University of Wisconsin–Madison
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals
Administration
Intravenous
01

Overview

89Zr-Df-huB12 is a zirconium-89 labeled humanized monoclonal antibody targeting fibroblast activation protein alpha (FAPα). It is developed as an immunoPET imaging agent to detect and monitor active fibrosis in diseases such as fibrotic interstitial lung disease (f-ILD) and radiation-induced pulmonary fibrosis (RIPF). The agent consists of the humanized anti-FAPα IgG antibody, huB12, conjugated to the chelator deferoxamine (Df) and radiolabeled with zirconium-89 (89Zr). By binding specifically to FAPα expressed on activated fibroblasts, 89Zr-Df-huB12 allows for non-invasive visualization and quantification of active fibrotic progression via PET/CT imaging.

Other names
[89Zr]Zr-huB1289Zr-Df-huB12 IgG89Zr-deferoxamine-huB1289Zr-huB12
02

Targets

FAP (Fibroblast activation protein alpha)

Beyond the preview

Go deeper on 89Zr-Df-huB12.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 89Zr-Df-huB12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call